A novel RNA molecular signature for activation of 2′-5′ oligoadenylate synthetase-1

Nucleic Acids Research

Volumn 43, Issue 1, 2015, Pages 544-552

  Vachon, Virginia K ^a,b   Calderon, Brenda M ^a   Conn, Graeme L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; DOUBLE STRANDED RNA; OAS1 PROTEIN, HUMAN; PYRIMIDINE DERIVATIVE; UNTRANSLATED RNA; VIRUS RNA;

CHEMISTRY; ENZYME ACTIVATION; GENETICS; HUMAN; METABOLISM; MUTAGENESIS; NUCLEOTIDE MOTIF;

2',5'-OLIGOADENYLATE SYNTHETASE; ENZYME ACTIVATION; HUMANS; MUTAGENESIS; NUCLEOTIDE MOTIFS; PYRIMIDINES; RNA, DOUBLE-STRANDED; RNA, UNTRANSLATED; RNA, VIRAL;

EID: 84941081421     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku1289     Document Type: Article

References (44)

1. Takeuchi, O., Akira, S. (2010) Pattern recognition receptors and inflammation. Cell, 140, 805-820.
2. Zust, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B.W., Ziebuhr, J., Szretter, K.J., Baker, S.C., Barchet, W., Diamond, M.S. et al. (2011) Ribose 2-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol., 12, 137-143.
3. Kowalinski, E., Lunardi, T., McCarthy, A.A., Louber, J., Brunel, J., Grigorov, B., Gerlier, D., Cusack, S. (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell, 147, 423-435.
4. Cole, J.L. (2007) Activation of PKR: an open and shut case? Trends Biochem. Sci., 32, 57-62.
5. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., Fujita, T. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol., 5, 730-737.
6. Silverman, R.H. (2007) Viral encounters with 2-, 5-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol., 81, 12720-12729.
7. Taguchi, T., Nagano-Fujii, M., Akutsu, M., Kadoya, H., Ohgimoto, S., Ishido, S., Hotta, H. (2004) Hepatitis C virus NS5A protein interacts with 2-, 5-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J. Gen. Virol., 85, 959-969.
8. Short, J.A.L. (2009) Viral evasion of interferon stimulated genes. Biosci. Horizons, 2, 212-224.
9. Zhang, R., Jha, B.K., Ogden, K.M., Dong, B., Zhao, L., Elliott, R., Patton, J.T., Silverman, R.H., Weiss, S.R. (2013) Homologous 2-, 5-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc. Natl. Acad. Sci. U.S.A., 110, 13114-13119.
10. Cayley, P.J., Davies, J.A., McCullagh, K.G., Kerr, I.M. (1984) Activation of the ppp(A2-p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2-p)nA-dependent RNase. Eur. J. Biochem., 143, 165-174.
11. Washenberger, C.L., Han, J.Q., Kechris, K.J., Jha, B.K., Silverman, R.H., Barton, D.J. (2007) Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L. Virus Res., 130, 85-95.
12. Alagarasu, K., Honap, T., Damle, I.M., Mulay, A.P., Shah, P.S., Cecilia, D. (2013) Polymorphisms in the oligoadenylate synthetase gene cluster and its association with clinical outcomes of dengue virus infection. Infect. Genet. Evol., 14, 390-395.
13. Lim, J.K., Lisco, A., McDermott, D.H., Huynh, L., Ward, J.M., Johnson, B., Johnson, H., Pape, J., Foster, G.A., Krysztof, D. et al. (2009) Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog., 5, e1000321.
14. Donovan, J., Dufner, M., Korennykh, A. (2013) Structural basis for cytosolic double-stranded RNA surveillance by human oligoadenylate synthetase 1. Proc. Natl. Acad. Sci. U.S.A., 110, 1652-1657.
15. Kodym, R., Kodym, E., Story, M.D. (2009) 2-5-Oligoadenylate synthetase is activated by a specific RNA sequence motif. Biochem. Biophys. Res. Commun., 388, 317-322.
16. Hartmann, R., Norby, P.L., Martensen, P.M., Jorgensen, P., James, M.C., Jacobsen, C., Moestrup, S.K., Clemens, M.J., Justesen, J. (1998) Activation of 2-5-oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers. J. Biol. Chem., 273, 3236-3246.
17. O'Malley, R.P., Mariano, T.M., Siekierka, J., Mathews, M.B. (1986) A mechanism for the control of protein synthesis by adenovirus VA RNAI. Cell, 44, 391-400.
18. Kitajewski, J., Schneider, R.J., Safer, B., Munemitsu, S.M., Samuel, C.E., Thimmappaya, B., Shenk, T. (1986) Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell, 45, 195-200.
19. Desai, S.Y., Patel, R.C., Sen, G.C., Malhotra, P., Ghadge, G.D., Thimmapaya, B. (1995) Activation of interferon-inducible 2-5-oligoadenylate synthetase by adenoviral VAI RNA. J. Biol. Chem., 270, 3454-3461.
20. Andersson, M.G., Haasnoot, P.C., Xu, N., Berenjian, S., Berkhout, B., Akusjarvi, G. (2005) Suppression of RNA interference by adenovirus virus-associated RNA. J. Virol., 79, 9556-9565.
21. Meng, H., Deo, S., Xiong, S., Dzananovic, E., Donald, L.J., van Dijk, C.W., McKenna, S.A. (2012) Regulation of the interferon-inducible 2-5-oligoadenylate synthetases by adenovirus VA(I) RNA. J. Mol. Biol., 422, 635-649.
22. Pe'ery, T., Mathews, M.B. (1997) Synthesis and purification of single-stranded RNA for use in experiments with PKR and in cell-free translation systems. Methods, 11, 371-381.
23. Linpinsel, J.L., Conn, G.L. (2012) General protocols for preparation of plasmid DNA template, RNA in vitro transcription, and RNA purification by denaturing PAGE. Methods Mol. Biol., 941, 43-58.
24. Walker, S.C., Avis, J.M., Conn, G.L. (2003) General plasmids for producing RNA in vitro transcripts with homogeneous ends. Nucleic Acids Res., 31, e82.
25. Wahid, A.M., Coventry, V.K., Conn, G.L. (2008) Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase. J. Biol. Chem., 283, 17485-17493.
26. Lu, C., Li, P. (2012) Preparation of short RNA by in vitro transcription. Methods Mol. Biol., 941, 59-68.
27. Sarkar, S.N., Pandey, M., Sen, G.C. (2005) Assays for the interferon-induced enzyme 2-, 5-oligoadenylate synthetases. Methods Mol. Med., 116, 81-101.
28. Justesen, J., Kjeldgaard, N.O. (1992) Spectrophotometric pyrophosphate assay of 2-, 5-oligoadenylate synthetase. Anal. Biochem., 207, 90-93.
29. Nielsen, S., Yuzenkova, Y., Zenkin, N. (2013) Mechanism of eukaryotic RNA polymerase III transcription termination. Science, 340, 1577-1580.
30. Coventry, V.K., Conn, G.L. (2008) Analysis of adenovirus VA RNAI structure and stability using compensatory base pair modifications. Nucleic Acids Res., 36, 1645-1653.
31. Sharp, T.V., Raine, D.A., Gewert, D.R., Joshi, B., Jagus, R., Clemens, M.J. (1999) Activation of the interferon-inducible (2-5-) oligoadenylate synthetase by the Epstein-Barr virus RNA, EBER-1. Virology, 257, 303-313.
32. Jeon, S.H., Lee, K., Lee, K.S., Kunkeaw, N., Johnson, B.H., Holthauzen, L.M., Gong, B., Leelayuwat, C., Lee, Y.S. (2012) Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett., 586, 3477-3484.
33. Le Roy, F., Salehzada, T., Bisbal, C., Dougherty, J.P., Peltz, S.W. (2005) A newly discovered function for RNase L in regulating translation termination. Nat. Struct. Mol. Biol., 12, 505-512.
34. Bevilacqua, P.C., Cech, T.R. (1996) Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry, 35, 9983-9994.
35. Ashkenazy, H., Erez, E., Martz, E., Pupko, T., Ben-Tal, N. (2010) ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res., 38, W529-W533.
36. Wreschner, D.H., McCauley, J.W., Skehel, J.J., Kerr, I.M. (1981) Interferon action-sequence specificity of the ppp(A2-p)nA-dependent ribonuclease. Nature, 289, 414-417.
37. Malathi, K., Dong, B., Gale, M. Jr and Silverman, R.H. (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature, 448, 816-819.
38. Giannelli, G., Antonelli, G., Fera, G., Dianzani, F., Schiraldi, O. (1993) 2, 5-Oligoadenylate synthetase activity as a responsive marker during interferon therapy for chronic hepatitis C. J. Interferon Res., 13, 57-60.
39. Jin, B., Cheng, L.F., Wu, K., Yu, X.H., Yeo, A.E. (2014) Application of dsRNA in cancer immunotherapy: current status and future trends. Anticancer Agents Med. Chem., 14, 241-255.
40. Rissland, O.S., Norbury, C.J. (2009) Decapping is preceded by 3-uridylation in a novel pathway of bulk mRNA turnover. Nat. Struct. Mol. Biol., 16, 616-623.
41. Choi, Y.S., Patena, W., Leavitt, A.D., McManus, M.T. (2012) Widespread RNA 3-end oligouridylation in mammals. RNA, 18, 394-401.
42. Fabre, O., Salehzada, T., Lambert, K., Boo Seok, Y., Zhou, A., Mercier, J., Bisbal, C. (2012) RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation. Cell Death Differ., 19, 1470-1481.
43. Yu, L., Yan, K., Liu, P., Li, N., Liu, Z., Zhu, W., Chen, Y., Han, D. (2014) Pattern recognition receptor-initiated innate antiviral response in mouse adipose cells. Immunol. Cell Biol., 92, 105-115.
44. Schoenfeld, J.D., Margalit, D.N., Kasperzyk, J.L., Shui, I.M., Rider, J.R., Epstein, M.M., Meisner, A., Kenfield, S.A., Martin, N.E., Nguyen, P.L. et al. (2013) A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin. Cancer Res., 19, 1612-1619.